Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19
Eric Yuk Fai Wan(Aston University), Esther W. Chan(University of Hong Kong), Wanchun Xu(Chinese University of Hong Kong), Philip H. Li(University of Cambridge), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Carlos King Ho Wong(University of Leicester), Francisco Tsz Tsun Lai(Hong Kong Science and Technology Parks Corporation), Boyuan Wang(Chinese University of Hong Kong), Anna Hoi Ying Mok(Chinese University of Hong Kong), Vincent Ka Chun Yan(University of Hong Kong), Benjamin J. Cowling(University of Hong Kong), Ian Chi Kei Wong(Department of Health), Franco Wing Tak Cheng(University of Hong Kong), Chak Sing Lau(University of Hong Kong), Xue Li(Department of Health), Celine Sze Ling Chui(University of Hong Kong)
Cited by 54
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3k
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis
|Gastroenterology|2020|1.7k
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19
|Radiology|2020|1.5k
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
|The Lancet Infectious Diseases|2014|965